Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG2PL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,790
Award facts
- Contract value 100% obligated
- $28,790.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,790.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-competitive, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order supports the Defense Health Agency's pharmaceutical supply chain requirements for diabetes and obesity management medications. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical role in the federal medical procurement ecosystem as a primary vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse pharmaceutical needs across multiple therapeutic domains, and this Zepbound delivery order represents a routine replenishment of specialty medications within the established prime vendor framework that enables flexible, rapid procurement of pharmaceutical products to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FG2PL?
SPE2DR26FG2PL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FG2PL worth?
The government has obligated $28,790 on SPE2DR26FG2PL.
Is contract SPE2DR26FG2PL an order under another contract?
Yes. SPE2DR26FG2PL is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2PL competed?
The extent of competition for SPE2DR26FG2PL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award